Founders Capital Management Merck & Co., Inc. Transaction History
Founders Capital Management
- $148 Million
- Q1 2024
A detailed history of Founders Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Founders Capital Management holds 44,925 shares of MRK stock, worth $5.65 Million. This represents 4.02% of its overall portfolio holdings.
Number of Shares
44,925
Previous 45,492
1.25%
Holding current value
$5.65 Million
Previous $4.96 Million
19.52%
% of portfolio
4.02%
Previous 3.61%
Shares
20 transactions
Others Institutions Holding MRK
# of Institutions
3,768Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.6 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.1 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.1 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $319B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...